Clinical trial
SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using…
NCT00124826 · University of Glasgow, Other · Completed
Key facts
| NCT number | NCT00124826 |
|---|---|
| Title | SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-Points |
| Official title | Spectroscopic Evaluation of Lesion Evolution in Stroke: Trial of Insulin for Acute Lactic Acidosis (SELESTIAL) |
| Lead sponsor | University of Glasgow, Other |
| Collaborators | South Glasgow University Hospitals NHS Trust The Stroke Association, United Kingdom |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Stroke, Hyperglycemia |
| Intervention type | Drug |
| Interventions | Insulin |
| Enrollment | 45 |
| Start date | May 1, 2004 |
| First posted | Jul 28, 2005 |
| Last update posted | Feb 1, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: